VERACYTE INC (VCYT) Stock Fundamental Analysis

NASDAQ:VCYT • US92337F1075

37.18 USD
-1.57 (-4.05%)
Last: Feb 27, 2026, 02:40 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, VCYT scores 6 out of 10 in our fundamental rating. VCYT was compared to 521 industry peers in the Biotechnology industry. VCYT has an excellent financial health rating, but there are some minor concerns on its profitability. VCYT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year VCYT was profitable.
  • In the past year VCYT had a positive cash flow from operations.
  • VCYT had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: VCYT reported negative operating cash flow in multiple years.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • The Return On Assets of VCYT (2.22%) is better than 88.68% of its industry peers.
  • With an excellent Return On Equity value of 2.41%, VCYT belongs to the best of the industry, outperforming 89.83% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 2.93%, VCYT belongs to the top of the industry, outperforming 89.83% of the companies in the same industry.
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROIC 2.93%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.12%, VCYT belongs to the top of the industry, outperforming 89.44% of the companies in the same industry.
  • VCYT's Operating Margin of 9.70% is amongst the best of the industry. VCYT outperforms 91.17% of its industry peers.
  • VCYT's Gross Margin of 68.53% is amongst the best of the industry. VCYT outperforms 81.38% of its industry peers.
  • VCYT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCYT is destroying value.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • VCYT has an Altman-Z score of 17.07. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 17.07, VCYT belongs to the best of the industry, outperforming 87.33% of the companies in the same industry.
  • VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.07
ROIC/WACC0.34
WACC8.69%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • VCYT has a Current Ratio of 6.23. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 6.23, VCYT is in the better half of the industry, outperforming 63.72% of the companies in the same industry.
  • A Quick Ratio of 5.94 indicates that VCYT has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 5.94, VCYT is doing good in the industry, outperforming 62.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.23
Quick Ratio 5.94
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 183.33%, which is quite impressive.
EPS 1Y (TTM)183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%783.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.55%

3.2 Future

  • Based on estimates for the next years, VCYT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.37% on average per year.
  • VCYT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.50% yearly.
EPS Next Y32.95%
EPS Next 2Y23.76%
EPS Next 3Y37.1%
EPS Next 5Y19.37%
Revenue Next Year11.27%
Revenue Next 2Y11.62%
Revenue Next 3Y11.28%
Revenue Next 5Y10.5%

3.3 Evolution

VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 43.74, which means the current valuation is very expensive for VCYT.
  • Based on the Price/Earnings ratio, VCYT is valued cheaply inside the industry as 90.21% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.11. VCYT is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 32.90, the valuation of VCYT can be described as expensive.
  • Based on the Price/Forward Earnings ratio, VCYT is valued cheaper than 91.36% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of VCYT to the average of the S&P500 Index (28.13), we can say VCYT is valued inline with the index average.
Industry RankSector Rank
PE 43.74
Fwd PE 32.9
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 91.94% of the companies in the same industry are more expensive than VCYT, based on the Enterprise Value to EBITDA ratio.
  • 93.86% of the companies in the same industry are more expensive than VCYT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 30
EV/EBITDA 37.73
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • VCYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • VCYT has a very decent profitability rating, which may justify a higher PE ratio.
  • VCYT's earnings are expected to grow with 37.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.33
PEG (5Y)N/A
EPS Next 2Y23.76%
EPS Next 3Y37.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for VCYT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VERACYTE INC

NASDAQ:VCYT (2/27/2026, 2:40:12 PM)

37.18

-1.57 (-4.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners114.83%
Inst Owner Change-4.95%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap2.94B
Revenue(TTM)N/A
Net Income(TTM)30.31M
Analysts82.11
Price Target50.17 (34.94%)
Short Float %7.16%
Short Ratio6.95
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0%
PT rev (3m)3.08%
EPS NQ rev (1m)4.03%
EPS NQ rev (3m)11.98%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)34.36%
Revenue NQ rev (1m)0.94%
Revenue NQ rev (3m)1.68%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)1.92%
Valuation
Industry RankSector Rank
PE 43.74
Fwd PE 32.9
P/S 5.94
P/FCF 30
P/OCF 27.28
P/B 2.34
P/tB 7.38
EV/EBITDA 37.73
EPS(TTM)0.85
EY2.29%
EPS(NY)1.13
Fwd EY3.04%
FCF(TTM)1.24
FCFY3.33%
OCF(TTM)1.36
OCFY3.67%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.33
PEG (5Y)N/A
Graham Number17.44
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROCE 3.71%
ROIC 2.93%
ROICexc 4.08%
ROICexgc 54.52%
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
FCFM 19.79%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.07%
Cap/Sales 1.97%
Interest Coverage 250
Cash Conversion 153.6%
Profit Quality 323.21%
Current Ratio 6.23
Quick Ratio 5.94
Altman-Z 17.07
F-Score8
WACC8.69%
ROIC/WACC0.34
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%783.33%
EPS Next Y32.95%
EPS Next 2Y23.76%
EPS Next 3Y37.1%
EPS Next 5Y19.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.55%
Revenue Next Year11.27%
Revenue Next 2Y11.62%
Revenue Next 3Y11.28%
Revenue Next 5Y10.5%
EBIT growth 1Y427.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year322.75%
EBIT Next 3Y73.63%
EBIT Next 5Y46.78%
FCF growth 1Y236.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.39%
OCF growth 3YN/A
OCF growth 5YN/A

VERACYTE INC / VCYT FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 6 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


How profitable is VERACYTE INC (VCYT) stock?

VERACYTE INC (VCYT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for VCYT stock?

The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 43.74 and the Price/Book (PB) ratio is 2.34.


What is the financial health of VERACYTE INC (VCYT) stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.